GB2429717B - Cell preservation method - Google Patents

Cell preservation method

Info

Publication number
GB2429717B
GB2429717B GB0625461A GB0625461A GB2429717B GB 2429717 B GB2429717 B GB 2429717B GB 0625461 A GB0625461 A GB 0625461A GB 0625461 A GB0625461 A GB 0625461A GB 2429717 B GB2429717 B GB 2429717B
Authority
GB
United Kingdom
Prior art keywords
preservation method
cell preservation
cell
preservation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0625461A
Other languages
English (en)
Other versions
GB2429717A (en
GB0625461D0 (en
Inventor
Jeremy Micah Crook
Lucy Kravets
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ES Cell International Pte Ltd
Original Assignee
ES Cell International Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004902933A external-priority patent/AU2004902933A0/en
Application filed by ES Cell International Pte Ltd filed Critical ES Cell International Pte Ltd
Publication of GB0625461D0 publication Critical patent/GB0625461D0/en
Publication of GB2429717A publication Critical patent/GB2429717A/en
Application granted granted Critical
Publication of GB2429717B publication Critical patent/GB2429717B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/16—Physical preservation processes
    • A01N1/162—Temperature processes, e.g. following predefined temperature changes over time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB0625461A 2004-06-02 2005-06-02 Cell preservation method Expired - Fee Related GB2429717B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2004902933A AU2004902933A0 (en) 2004-06-02 Cell preservation method
AU2005902548A AU2005902548A0 (en) 2005-05-18 Cell preservation method 2
PCT/AU2005/000783 WO2005118785A1 (en) 2004-06-02 2005-06-02 Cell preservation method

Publications (3)

Publication Number Publication Date
GB0625461D0 GB0625461D0 (en) 2007-02-07
GB2429717A GB2429717A (en) 2007-03-07
GB2429717B true GB2429717B (en) 2009-04-08

Family

ID=35462905

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0625461A Expired - Fee Related GB2429717B (en) 2004-06-02 2005-06-02 Cell preservation method

Country Status (7)

Country Link
US (3) US9714412B2 (cg-RX-API-DMAC7.html)
EP (1) EP1765986A4 (cg-RX-API-DMAC7.html)
JP (1) JP2008501320A (cg-RX-API-DMAC7.html)
CA (1) CA2569485C (cg-RX-API-DMAC7.html)
GB (1) GB2429717B (cg-RX-API-DMAC7.html)
IL (1) IL179785A (cg-RX-API-DMAC7.html)
WO (1) WO2005118785A1 (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10076824B2 (en) 2007-12-17 2018-09-18 Smith International, Inc. Polycrystalline diamond construction with controlled gradient metal content
US10124468B2 (en) 2007-02-06 2018-11-13 Smith International, Inc. Polycrystalline diamond constructions having improved thermal stability

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008501320A (ja) 2004-06-02 2008-01-24 イーエス・セル・インターナショナル・プライヴェート・リミテッド 細胞保存方法
US8794013B2 (en) * 2006-02-10 2014-08-05 Praxair Technology, Inc. Method and system for nucleation control in a controlled rate freezer (CRF)
GB0605450D0 (en) * 2006-03-17 2006-04-26 Intercytex Ltd Cell co-culture
US7942219B2 (en) 2007-03-21 2011-05-17 Smith International, Inc. Polycrystalline diamond constructions having improved thermal stability
GB0719751D0 (en) 2007-10-10 2007-11-21 Antoxis Ltd In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
ES2743693T3 (es) * 2009-04-29 2020-02-20 Biolife Solutions Inc Aparatos y composiciones para crioconservación de monocapas celulares
ITTO20090797A1 (it) * 2009-10-21 2011-04-22 Lucia Maria Moriondo Metodo e soluzione per la crioconservazione di embrioni umani
EP2537030B1 (en) 2010-02-19 2017-08-30 Cadila Pharmaceuticals Ltd. A pharmaceutical composition of killed cells with substantially retained immunogenicity
GB201017315D0 (en) 2010-10-13 2010-11-24 Antoxis Ltd Compound
US20140335614A1 (en) * 2011-12-21 2014-11-13 Biocision, Llc Method and devices for cryopreservation of biomaterials
WO2014037807A2 (en) * 2012-09-07 2014-03-13 Biolamina Ab Stem cell bank
GB201222241D0 (en) 2012-12-11 2013-01-23 Morris George J Control of ice formation
FR3035407B1 (fr) 2015-04-23 2022-06-17 Francais Du Sang Ets Procede de conservation de cellules, tissus ou organes en hypothermie
CN108291207A (zh) 2015-10-08 2018-07-17 神经元治疗公司 神经前体细胞群体及其用途
EP3386297B1 (en) 2015-12-07 2025-04-23 CooperSurgical, Inc. Low temperature specimen carriers
EP3407844A4 (en) * 2016-01-29 2019-10-16 Qool Therapeutics, Inc. AEROSOLISATION OF STEM CELLS OR STEM CELL DERIVATIVES FOR PULMONARY ADMINISTRATION
EP3455346A1 (en) 2016-05-12 2019-03-20 Erasmus University Medical Center Rotterdam A method for culturing myogenic cells, cultures obtained therefrom, screening methods, and cell culture medium
NL2019517B1 (en) 2017-09-08 2019-03-19 Univ Erasmus Med Ct Rotterdam New therapy for Pompe disease
JP7491533B2 (ja) * 2019-11-20 2024-05-28 住友ファーマ株式会社 神経系細胞の凍結方法
US20240352425A1 (en) * 2021-01-19 2024-10-24 Gallant Pet. Inc. Methods for optimizing reproductive tissue derived cell yield and viability for clinical applications
US12471592B2 (en) 2021-08-18 2025-11-18 Reelabs Private Limited Cytoprotective compositions for short-term cells storage and transportation without cryopreservation and deep freezing
CN116602292B (zh) * 2023-05-29 2026-01-02 广西壮族自治区水牛研究所 一种利用冻精管冻存生物细胞的方法
WO2025160465A1 (en) 2024-01-26 2025-07-31 Celularity Inc. A method of treating signs or symptoms of the aging process

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0246824A2 (en) * 1986-05-15 1987-11-25 Cell Systems Ltd Biological cryoprotection
GB2330516A (en) * 1997-10-22 1999-04-28 Elizabeth Acton Cryopreservation of cell suspensions
WO2004010780A2 (en) * 2002-07-30 2004-02-05 General Biotechnology, Llc Innocuous intracellular ice

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891617A (en) 1993-09-15 1999-04-06 Organogenesis Inc. Cryopreservation of harvested skin and cultured skin or cornea equivalents by slow freezing
EP1263932A4 (en) 2000-03-14 2004-06-23 Es Cell Int Pte Ltd EMBRYONIC CELLS AND NEURONAL STEM CELLS DERIVED THEREFROM
KR20050008757A (ko) * 2002-05-30 2005-01-21 셀진 코포레이션 세포 분화를 조절하고 골수증식성 질환 및 골수형성이상증후군을 치료하기 위하여 ｊｎｋ 또는 ｍｋｋ 저해제를사용하는 방법
JP2006525006A (ja) 2003-05-08 2006-11-09 セルアーティス アーベー 閉塞ストローガラス化方法を利用するヒト胚盤胞由来幹細胞の低温保存法
JP2008501320A (ja) 2004-06-02 2008-01-24 イーエス・セル・インターナショナル・プライヴェート・リミテッド 細胞保存方法
US7811819B2 (en) * 2005-05-31 2010-10-12 The University Of Washington Cryopreservation of primate embryonic stem cells

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0246824A2 (en) * 1986-05-15 1987-11-25 Cell Systems Ltd Biological cryoprotection
GB2330516A (en) * 1997-10-22 1999-04-28 Elizabeth Acton Cryopreservation of cell suspensions
WO2004010780A2 (en) * 2002-07-30 2004-02-05 General Biotechnology, Llc Innocuous intracellular ice

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Cryobiology (1970); Vol 6, pp 315-332, "Effects of freezing on marrow stem cell...", Leibo *
Human Reproduction (2001); Vol 16, pp 2187-2194, "Effective cryopreservation of human...", Reubinoff et al *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10124468B2 (en) 2007-02-06 2018-11-13 Smith International, Inc. Polycrystalline diamond constructions having improved thermal stability
US10076824B2 (en) 2007-12-17 2018-09-18 Smith International, Inc. Polycrystalline diamond construction with controlled gradient metal content

Also Published As

Publication number Publication date
US20200208104A1 (en) 2020-07-02
CA2569485C (en) 2015-08-18
US20170275588A1 (en) 2017-09-28
US9714412B2 (en) 2017-07-25
EP1765986A4 (en) 2007-11-07
CA2569485A1 (en) 2005-12-15
IL179785A (en) 2014-09-30
WO2005118785A1 (en) 2005-12-15
US20080057040A1 (en) 2008-03-06
US10472606B2 (en) 2019-11-12
JP2008501320A (ja) 2008-01-24
EP1765986A1 (en) 2007-03-28
IL179785A0 (en) 2007-05-15
GB2429717A (en) 2007-03-07
GB0625461D0 (en) 2007-02-07

Similar Documents

Publication Publication Date Title
GB2429717B (en) Cell preservation method
GB0420061D0 (en) Method
GB0402639D0 (en) Method
GB0422733D0 (en) Method
GB0410478D0 (en) Method
GB0418651D0 (en) Method
GB0422730D0 (en) Method
GB0419419D0 (en) Method
GB0415009D0 (en) Method
GB0412659D0 (en) Method
GB0412672D0 (en) Method
GB0423871D0 (en) Method
GB2412119B (en) Method
GB2417739B (en) Method
GB0428327D0 (en) Method
GB0415081D0 (en) Method
AU2004902933A0 (en) Cell preservation method
GB0427916D0 (en) Method
GB0413714D0 (en) Method
AU2005902548A0 (en) Cell preservation method 2
GB0422162D0 (en) Method
GB0422158D0 (en) Method
GB0422732D0 (en) Method
GB0410872D0 (en) Method
GB0402123D0 (en) Method

Legal Events

Date Code Title Description
R108 Alteration of time limits (patents rules 1995)

Free format text: EXTENSION APPLICATION

Effective date: 20090127

Free format text: EXTENSION ALLOWED

Effective date: 20090212

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20210602